ArticleProceedings (Baylor University. Medical Center)2026
Adherence to guideline-recommended management in acute severe ulcerative colitis: a retrospective audit.
Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- We can do better by our patients hospitalized with acute severe ulcerative colitis.Proceedings (Baylor University. Medical Center) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute severe ulcerative colitis (ASUC) is a life-threatening complication of ulcerative colitis that requires hospitalization and prompt guideline-directed management. We evaluated adherence to recommended inpatient management in hospitalized patients with ASUC.
methodsWe conducted a single-center retrospective audit of patients hospitalized with ASUC at a tertiary care center from 2014 to 2024. ASUC was defined using Truelove and Witts' criteria. Patients <18 years were excluded. The primary outcome was venous thromboembolism (VTE) prophylaxis. Secondary outcomes included
resultsAmong 530 encounters reviewed, 35 patients met inclusion criteria, accounting for 56 admissions. VTE prophylaxis was administered in 43% of admissions, CMV testing in 30%, and
conclusionsAdherence to guideline-recommended ASUC management was variable, particularly for VTE prophylaxis and CMV testing, both of which improved significantly following the 2019 ACG guideline publication, underscoring the impact of guideline dissemination and highlighting remaining targets for quality improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.